EMA approves rival to GSK, AZ asthma meds; British AF patients often untreated, report says;

@FiercePharma: Now, Icahn questions Forest CEO's $500m in stock sales; Forest calls it a "theatrical display of self-serving rhetoric." More | Follow @FiercePharma

> SkyePharma won European approval for its asthma treatment Flutiform, a rival to GlaxoSmithKline's ($GSK) Advair and AstraZeneca's ($AZN) Symbicort. Report

> A U.K. report found that 360,000 patients with atrial fibrillation are either untreated or treated only with aspirin, rather than prescription blood thinners. Report

> The use of antipsychotic drugs during pregnancy appears to increase the risk of gestational diabetes, a new study finds. Report

> NPS Pharmaceuticals ($NPSP) gave up some royalty payments from Amgen ($AMGN), opting for more time to repay a previous advance on royalties from Sensipar. Report

> Jefferies analysts started covering Indian generics makers Ranbaxy Laboratories, Sun Pharmaceuticals and CIpla with a "buy" rating, citing their emerging markets sales. Report

Biotech News

 @FierceBiotech: Researchers shatter record with U.S.-China genomic data transfer. News | Follow @FierceBiotech

@JohnCFierce: Rodman's Michael King says 'whoops' on Amylin, believes Vivus and MannKind (huh?) next likely diabetes targets. Item | Follow @JohnCFierce

 @RyanMFierce: A good job rounding up the early-stage biotech VC usual suspects. More | Follow @RyanMFierce

> GlobeImmune's $69M IPO designed to build immunotherapy pipeline. Article

> In R&D showdown, Genentech beat Roche in a TKO. Story

> J&J rushes drug-resistant TB therapy bedaquiline to FDA. News

Medical Device News

@FierceMedDev: CareFusion has staged a Class I recall of some of its infant breathing devices. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Roche continues to expand its diagnostics business with an FDA nod for a new HIV test. Story | Follow @DamianFierce

> SEC suspends China Medical trading amid accuracy concerns. More

> CareFusion stages Class I recall of infant breathing device. News

> CVRx launches registry to track hypertension-device patients. Item

> Wright looking to recapture profits with foot-reconstruction tech. Article

Biotech Research News

> Promising mouse study lays foundation for startup's autism drug program. Article

> In breakthrough, stem cell transplants reverse diabetes in mice. Story

> Texas cancer research funding effort may shift to startups. Item

> Mayo Clinic researchers find novel way to repair MS damage. News

Pharma Manufacturing News

> GlaxoSmithKline's Witty says manufacturing must become more efficient. More

> J&J recalls 69,000 units of K-Y vaginal lubricant. News

> United snags Glaxo buildings as it completes expansion. Story

> ScinoPharm building new cancer injectables plant in China. Article

Biomarkers News

> Marker helps docs pick kids' bone cancer treatment. Story

> Developing proteomic signatures focus pancreatic cancer therapy. Article

> Heart size distorts biomarker levels. More

> Apolipoproteins mark diabetic visual loss. Item

> Biomarkers spot hep C liver disease. Story

And Finally... Women infected with a common parasite have an increased risk of suicide. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.